The Manila Times

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

ADMA Biologics, Inc. (Nasdaq: ADMA) ('ADMA” or the 'Company”), a U.S. based, end-to-end commercial biopharmaceutical company ...